1. Search Result
Search Result
Results for "

Drug-likeness

" in MCE Product Catalog:

8

抑制剂 & 激动剂

17

化合物筛选库

没找到您心仪的产品?我们拥有更多针对信号通路的抑制剂、激动剂、调节剂

您还可以尝试以下方式,我们的专业人员为您服务

Cat. No. Product Name
  • HY-L0091V
    1,367,511 compounds
    Chemspace Lead-Like Compound Library contains 1,367,511 in-Stock lead-like compoundswith favorable physicochemical profiles and high Quantitative Estimation of Drug-likeness.
  • HY-L0113V
    1,000,000 compounds

    MCE 1M Drug Fragment-Based Diversity Library 由 100 万种类药化合物组成。该分子库中的每个化合物都含有至少 1个 较复杂的药物片段,这些药物片段来自 FDA批准的 2,946 个药物分子,以提高化合物的类药性。计算化合物的 BMS (Bemis-Murcko Scaffold) 骨架后,每个 BMS 骨架选择 1~3 个药物片段数较高的化合物,以占据更广泛的“类药化学空间”。

    本多样性库具备类药性,化合物骨架多样性等特性,是发现先导化合物的有力工具,可以广泛应用于AI药物筛选、大型虚拟筛选等。

  • HY-L910V
    50,000 compounds

    MegaUni 库为运用生成式人工智能技术,构建出的兼具新颖性、类药性、多样性、可合成性的超大化合物库。适用于AI药物筛选、大型虚拟筛选等。

    MCE 依托强大的计算能力,基于高质量的 40,662 个分子砌块,匹配合适的反应规则,选择最优的化合物生成策略,去除合成难度高、类药性低、PAINS等不利化合物后,进一步分析化合物骨架,优选出类药多样性分子组成虚拟库。随后随机挑选库中分子,进行合成验证,再次剔除合成难度高的分子,经迭代优化后,最终生成含 1000 万可合成类药多样性分子的 MegaUni 10M Virtual Diversity Library。

    优选 50,000 个分子组成 MegaUni 50K Virtual Diversity Library。50,000 个分子具有 46,744 种 BMS 分子骨架,每种分子骨架仅包含 1-3 个化合物,化学空间多样,结构新颖,适用于新型先导物发现等。

  • HY-L0103V
    680,000 compounds
    UORSY Screening Compounds Library contains about 680,000 compounds. The library has extensively developed a polymerization synthesis method that provides a highly diverse chemical structure. More than 85% of the compounds in the library have drug-like physicochemical properties, and more than 35% of the compounds have lead-like properties.
  • HY-L0093V
    10,119 compounds
    Diversity-based screening continues to be a vital tool for drug discovery. Efficiency and productivity can be improved by using screening libraries that offer maximum diversity whilst retaining drug-like properties. Chemspace Scaffold derived set composes 10,119 compounds, which including 3,373 scaffolds, 3 compounds per each. This library has exceptional coverage of drug-like chemical space.
  • HY-L200
    2,703 compounds

    天然产物是自然界中产生的,来自于任何生物体的小分子化合物,其中包括初级代谢物及次级代谢物。天然产物具有潜在的生物活性,可以作为药物发现的先导化合物。数千年来,大自然一直是药物的来源,大量现代药物从自然界中分离得到,许多是基于它们在传统医学中的用途。随着化合物靶点的开发,对筛选化合物多样性的需求越来越大。通过对自然界生物多样性的持续研究,其中许多生物多样性仍有待开发,天然产物将在满足这一需求方面发挥关键作用。类药五原则(Lipinski rule of 5)是用来描述一个分子类似药物的性质,遵守5法则的分子具有更高的药物潜力。MCE 在已有天然产物库的基础之上,筛选出了符合类药五原则的分子,使得药物筛选的效率更高。

    MCE收录了 2,703 个符合 RO5 类性的药物天然产物,是药物发现的重要工具。

  • HY-L912V
    10,000,000 compounds

    MegaUni 库为运用生成式人工智能技术,构建出的兼具新颖性、类药性、多样性、可合成性的超大化合物库。适用于AI药物筛选、大型虚拟筛选等。

    MCE 依托强大的计算能力,基于高质量的 40,662 个分子砌块,匹配合适的反应规则,选择最优的化合物生成策略,去除合成难度高、类药性低、PAINS等不利化合物后,进一步分析化合物骨架,优选出类药多样性分子组成虚拟库。随后随机挑选库中分子,进行合成验证,再次剔除合成难度高的分子,经迭代优化后,最终生成含 1000 万可合成类药多样性分子的 MegaUni 10M Virtual Diversity Library。

    库中化合物仅需1-2步化学反应即可合成,借助 MCE 经验丰富的化学合成团队,可以轻松实现从 mg 级到 kg级等不同量级的定制合成,满足不同客户需求。

  • HY-L0094V
    1,398,968 compounds
    The Chinese National Compound Library (CNCL) composes 1.4 million compounds possessing diversified structures. Coupled with this library will be advanced sample handling, information management and quality control systems. Most compounds in the library are drug-like, conforming to “Lipinski’s Rule of Five”, such as MW < 500, logP < 5, Hydrogen Bond Donors < 5.
  • HY-L0123V
    30,300 compounds

    The incidence and significance of central nervous system diseases are increasing at an alarming rate all over the world. Although substantial research efforts have been applied to develop new CNS-active drugs, only a few CNS disorders are addressed satisfactorily, while the remaining ones pose significant clinical challenges. Blood-brain barrier (BBB) permeability is one of the most important limiting factors in the design and development of novel CNS-targeted pharmaceuticals for the treatment of neurological disorders.

    Carefully selected from the HTS Compound Collection to meet the parameters optimized for high BBB-permeability, our CNS Focused Screening Library comprising over 30,300 structurally-diverse and potentially CNS-active screening compounds. This original Screening Compound Library is aimed at supporting CNS drug design projects and HTS efforts in search for novel neurotherapeutics.

  • HY-L0079V
    2,470 compounds
    A specially synthesized set of 2 compounds able to mimic glycosides and their interaction with proteins. The main emphasis of library design was made on drug-like compounds enriched with H-bond donors (possess at least two H-bond donors) and bearing nature-like Fsp3–rich scaffolds with diverse spatial orientation of H-bond donors and different 3D-shapes.
  • HY-L905
    5,000 compounds

    历史上,天然产物在药物发现中起着关键的作用,特别是在癌症和传染病的治疗领域,其他的治疗领域也包括心血管疾病(如他汀类药物),多发性硬化症(如腺苷酯)等。过去的几十年里,FDA批准的药物中大约有40%是天然产物,其衍生物或与天然产物相关的类似物。

    MCE Natural Product-like Compound Library 由5,000个来自类药库的类天然产物化合物组成,库中每个分子含有天然产物关键骨架(42个)或者和天然产物的谷本相似系数大于0.6,且Natural-likeness scoring>-2,该化合物库同时具备类药性和新颖性,库中化合物可重复供应,是新药研发的有力工具,可以广泛地应用于高通量筛选(HTS)和高内涵筛选(HCS)。

  • HY-L0087V
    503,810 compounds
    Life Chemicals Collection of small organic molecules for high-throughput screening currently contains 503,810 off-the-shelf products. The Collection is being permanently replenished with de novo designed products having optimal physicochemical parameters for drug discovery.
  • HY-L0116V
    1,065 compounds

    Macrocycles are promising scaffolds for the design of novel RNA targeting molecules. This collection of macrocycles for RNA consists of very diverse, drug-like molecules which incorporate certain known RNA-recognition elements (e.g. nucleobase ring systems and analogs) distributed within macrocyclic rings or peripheral fragments. As macrocyclic molecules tend to be larger than traditional screening molecules, it is vital to carefully assess and control their physicochemical properties. All macrocycles have been tested for aqueous and DMSO solubility with cutoffs applied at 10 mM in DMSO and 50 µM in PBS (pH 7.4); PAMPA permeability has also been tested for representative set of macrocycles.

  • HY-L0121V
    10,000 compounds

    Natural products are an attractive source with varied structures that exhibit potent biological activities, and desirable pharmacological profiles. The core scaffold of a natural product can also provide a biologically validated framework upon which to display diverse functional groups. Inspired by bioactive natural products, natural product-like compounds, occupying the same chemical space, are ideally suited to explore and to facilitate understanding of biological pathways.

    MCE 10K Natural Product-like Compound Library consists of 10,000 natural product-like compounds. Each compound has scaffold of natural products or Tanimoto coefficient >0.6 with natural products. The natural-likeness scoring of these compounds is >-2. What’s more, compounds in the library are drug-like and readily available for re-supply, making it a powerful tool for new drug research and development. It can be widely applied in high-throughput screening (HTS) and high-content screening (HCS).

  • HY-L137
    40 compounds

    靶向蛋白降解(Targeted protein degradation, TPD)是一种新型的、有前景的新药研发方法。它在靶向“不可成药”疾病靶点及克服耐药性问题上显示了巨大的潜力。分子胶和PROTACs都是目前最受关注的两种靶向蛋白降解技术。

    分子胶是一种小分子降解剂,主要诱导E3泛素连接酶与靶蛋白之间发生新型相互作用,形成三元复合物,导致蛋白质泛素化,随后被蛋白酶体降解。与PROTACs相比,分子胶通常具有更好的类药性,如具有更低的分子量,更高的细胞通透性和更好的口服吸收度等。分子胶已经逐渐成为一种具有前景的疾病治方法。

    MCE 收录了40种靶向不同蛋白的分子胶化合物。MCE分子胶化合物库是进行科学研究和疾病机制研究的有用工具。

  • HY-L0105V
    485,000 compounds
    InterBioScreen Synthetic Compounds Library contains about 485,000 immediately available compounds. The library is generated by very rigorously selecting the most interesting classes of compounds that are most likely to become new drugs or plant protection agents or veterinary preparations.
  • HY-L0092V
    53,000 compounds
    Maybridge Screening Collection is a highly diverse set of over 53 hit-like and lead-like molecules widely acknowledged as a critical tool in screening campaigns.

Your information is safe with us. * Required Fields.

* 客户姓名:

 

* 公司或机构名称:

* Email:

 

* 联系电话:

* 产品名称:

 

* 需求量:

   目录号:

 

   CAS号:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
目录号:
需求量: